8-PHENYL-ISOQUINOLINES AND PHARMACEUTICAL COMPOSITION THEREOF USED IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME
申请人:Yu Linda Chia-Hui
公开号:US20200071274A1
公开(公告)日:2020-03-05
A series of 8-phenyl-isoquinoline derivatives (I) exhibit high binding affinity to 5-HT
7
receptor (5-HT7R) and demonstrate potent antinociceptive activity in two animal models for Irritable Bowel Syndrome (IBS) by intraperitoneal injection (i.p.) or by oral administration (p.o.). These 5-HT
7
receptor antagonists are a new class of therapeutic agents for the treatment of IBS.